Alphabet Inc.

Holdings History for Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA)

Symbol: VERA on Nasdaq
Investment type: Equity / Class A common stock, $0.001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.47%	0%	$12,217,609	241,264	0		$50.64	Q4 2025
30 Sep 2025	0.29%	0%	$7,011,132	241,264	0		$29.06	Q3 2025
30 Jun 2025	0.27%	0%	$5,684,180	241,264	0		$23.56	Q2 2025
31 Mar 2025	0.37%	0%	$5,795,161	241,264	0		$24.02	Q1 2025
31 Dec 2024	0.59%	0%	$10,203,056	241,264	0		$42.29	Q4 2024
30 Sep 2024	0.58%	0%	$10,663,869	241,264	0		$44.20	Q3 2024
30 Jun 2024	0.44%	0%	$8,728,932	241,264	0		$36.18	Q2 2024
31 Mar 2024	0.41%	-0.1%	$10,403,303	241,264	-60,316	-20%	$43.12	Q1 2024
31 Dec 2023	0.22%	0%	$4,638,300	301,580	0		$15.38	Q4 2023
30 Sep 2023	0.27%	0%	$4,134,661	301,580	0		$13.71	Q3 2023
30 Jun 2023	0.26%	0%	$4,840,359	301,580	0		$16.05	Q2 2023
31 Mar 2023	0.13%	0%	$2,340,261	301,580	0		$7.76	Q1 2023
31 Dec 2022	0.34%	0%	$5,835,573	301,580	0		$19.35	Q4 2022
30 Sep 2022	0.33%	0%	$6,427,000	301,580	0		$21.31	Q3 2022
30 Jun 2022	0.22%	0%	$4,105,000	301,580	0		$13.61	Q2 2022
31 Mar 2022	0.23%	-0.31%	$7,084,000	301,580	-412,078	-58%	$23.49	Q1 2022
31 Dec 2021	0.46%	-0.15%	$19,069,000	713,658	-231,133	-24%	$26.72	Q4 2021
30 Sep 2021	0.39%	0%	$16,392,000	944,791	0		$17.35	Q3 2021
30 Jun 2021	0.26%	+0.26%	$12,528,000	944,791	+944,791	NEW	$13.26	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.